NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression

Go back to NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
(NASDAQ: ELAB) Delayed: 4.71 -0.14 (2.89%)
Previous Close $4.85    52 Week High
Open $4.80    52 Week Low
Day High $4.89    P/E N/A 
Day Low $4.61    EPS
Volume 24,677